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Introduction {#jcsm12048-sec-0005}
============

Sarcopenia was originally defined as age‐related loss of muscle mass.[1](#jcsm12048-bib-0001){ref-type="ref"}, [2](#jcsm12048-bib-0002){ref-type="ref"} Recently, a number of definitions of sarcopenia have been suggested that include a functional measure (e.g. limited mobility) together with appendicular lean mass corrected for height.[3](#jcsm12048-bib-0003){ref-type="ref"}, [4](#jcsm12048-bib-0004){ref-type="ref"}, [5](#jcsm12048-bib-0005){ref-type="ref"} Others have argued that muscle strength or power is a more appropriate addition to loss of muscle mass or that a new term dynapenia (poverty of muscle strength/power) should be used separately from sarcopenia, which then would be reserved solely for poverty of muscle mass.[6](#jcsm12048-bib-0006){ref-type="ref"}, [7](#jcsm12048-bib-0007){ref-type="ref"}, [8](#jcsm12048-bib-0008){ref-type="ref"} Regardless of definitional refinements, sarcopenia measured in several different ways has been associated with multiple adverse outcomes.[3](#jcsm12048-bib-0003){ref-type="ref"}, [4](#jcsm12048-bib-0004){ref-type="ref"}, [5](#jcsm12048-bib-0005){ref-type="ref"} No easily applied sarcopenia measure currently exists for use in usual clinical settings.

In the osteoporosis field, it has been demonstrated that a simple questionnaire (FRAX) can predict persons with elevated risk of osteoporotic fracture without the requirement of measuring bone mineral density (BMD).[9](#jcsm12048-bib-0009){ref-type="ref"}, [10](#jcsm12048-bib-0010){ref-type="ref"} As loss of muscle mass, unlike loss of bone, has a clear clinical symptom, that is, weakness, it should be possible to create a simple symptom score that will predict both sarcopenia and poor outcomes in persons with sarcopenia.

Our group has been conducting a panel study of community‐dwelling, late middle‐aged African Americans who were 49--65 years of age at cohort initiation in 2000--01, have high levels of disability,[11](#jcsm12048-bib-0011){ref-type="ref"}, [12](#jcsm12048-bib-0012){ref-type="ref"} and are known collectively as the African American Health (AAH) cohort. Previously, we have shown in this cohort that the increase in disability over 9 years can be predicted in those with limited mobility and low lean mass,[13](#jcsm12048-bib-0013){ref-type="ref"} but this measure requires in‐person and laboratory assessments. The Baltimore Longitudinal Study of Aging (BLSA) and National Health and Nutrition Examination Survey (NHANES) cohorts also include data that can be utilized to examine sarcopenia. In this study, we examine the validity of a simple clinical symptom index (SARC‐F)[14](#jcsm12048-bib-0014){ref-type="ref"} to screen for sarcopenia/dynapenia and to identify those at risk for sarcopenia‐related adverse outcomes in AAH, BLSA, and NHANES.

Materials and methods {#jcsm12048-sec-0006}
=====================

Study sample {#jcsm12048-sec-0007}
------------

The AAH project sampling and recruitment procedures have been described elsewhere.[12](#jcsm12048-bib-0012){ref-type="ref"} In brief, AAH is a population‐based longitudinal study of 998 African Americans from St. Louis, MO. Recruitment was performed using multistage probability sampling methodology designed to select approximately equal numbers of participants from two geographic strata, an inner‐city area and near suburban neighbourhoods northwest of the city. AAH eligibility criteria included living independently (i.e. not institutionalized), self‐reported black or African American race, birth year between 1936 and 1950, and a Mini‐mental State Examination score of 16 or greater (98% ≥ 20). Recruitment proportion (participants/enumerated eligible persons) in 2000--01 was 76%. AAH Wave 1 (baseline) in‐home interviews included *n* = 998 participants evaluated in 2000--01. Follow‐up in‐home interviews were done at in 2003--04 (Wave 4; *n* = 853) and 2010--11 (Wave 10; *n* = 582). The analytic sample for this report includes *n* = 853 Wave 4 respondents and outcomes at their 6 year follow‐up (Wave 10). The institutional review board at Saint Louis University approved this project.

The BLSA was started in 1958 and is an ongoing longitudinal study of normal human aging.[15](#jcsm12048-bib-0015){ref-type="ref"} BLSA participation is limited to adults who at the time of enrollment screening do not have major diseases, cognitive dysfunction, or functional impairment but once enrolled are followed for life. BLSA participants complete comprehensive health testing on a repeated cycle (1--4 years). The analytic sample for this study includes *n* = 1053 BLSA participants evaluated between April 2003 and December 2012 who were ages 60 and above and had valid data on the five items needed to construct the SARC‐F and outcomes at follow‐up (27.07 ± 11.7 months).

The NHANES 1999--2006 is an annual cross‐sectional, nationally representative survey of approximately 5000 non‐institutionalized individuals in the United States.[16](#jcsm12048-bib-0016){ref-type="ref"} NHANES data are publically released in 2 year cycles. The primary objective of NHANES is to collect a comprehensive data set that can be utilized to assess the health and nutritional status of the national population of children and adults. NHANES data for 1999--2002 include *n* = 21 004 participants with a median age of 19 (interquartile range 10--48) and 51.4% women. The analytic sample for this study includes *n* = 3288 NHANES 1999--2002 participants who were ages 60--85 with valid data on the five items needed to construct the SARC‐F.

SARC‐F questionnaire (0--10 points) {#jcsm12048-sec-0008}
-----------------------------------

SARC‐F includes five components: strength, assistance walking, rise from a chair, climb stairs, and falls. SARC‐F items were selected to reflect health status changes associated with the consequences of sarcopenia.[3](#jcsm12048-bib-0003){ref-type="ref"}, [4](#jcsm12048-bib-0004){ref-type="ref"} SARC‐F scale scores range from 0 to 10 (i.e. 0--2 points for each component; 0 = *best* to 10 = *worst*) and were dichotomized to represent symptomatic (4+) vs. healthy (0--3) status. The SARC‐F scale was constructed using the same questions in AAH and BLSA. Strength was measured by asking respondents how much difficulty they had lifting or carrying 10 lbs. (0 = *no difficulty*, 1 = *some*, and 2 = *a lot or unable to do*). Assistance walking was assessed by asking participants how much difficulty they had walking across a room and whether they use aids or need help to do this (0 = *no difficulty*, 1 = *some difficulty*, and 2 = *a lot of difficulty, use aids, or unable to do without personal help*). Rise from a chair was measured by asking respondents how much difficulty they had transferring from a chair or bed and whether they used aids or needed help to do this (0 = *no difficulty*, 1 = *some difficulty*, and 2 = *a lot of difficulty, use aids, or unable to do without help*). Climb stairs was measured by asking respondents how much difficulty they had climbing a flight of 10 steps (0 = *no difficulty*, 1 = *some*, and 2 = *a lot or unable to do*). Falls was scored a 2 for respondents who reported falling four or more times in the past year, 1 for respondents who reported falling 1--3 times in the past year, and 0 for those reporting no falls in the past year. SARC‐F construction in NHANES used the same strength and climb stairs items as in AAH and BLSA. There were minor wording differences in the NHANES items for assistance walking (assessed by asking difficulty walking between rooms on the same floor) and rise from a chair (assessed by asking difficulty standing up from armless chair). NHANES did not ask participants to report the specific number of falls in the past year but did ask about difficulty with balance or falling in past year. The NHANES SARC‐F falls was scored a 2 for respondents who reported falling problems in the past year, 1 for respondents who reported only balance problems in the past year, and 0 for those reporting no falling or balance problems in the past year.

Criterion validation measures {#jcsm12048-sec-0009}
-----------------------------

We examined the associations of SARC‐F with muscle (lean mass per cent and total lean mass) and the short portable sarcopenia measure (SPSM) in the AAH cohort. The portable Tanita Ultimate Scale Model 2001 (Tanita Corporation of America, Arlington Heights, IL) bioelectrical impedance program was used to measure lean mass per cent (1 minus body fat per cent) and total lean mass \[(1 minus body fat per cent) × body weight in lbs\]. The SPSM scale is a brief field measure for sarcopenia that includes three components: upper body relative strength (grip strength/height), lower body power and strength (timed chair stands), and lean mass \[(1 minus body fat per cent) × (body weight in kg/height in m^2^)\], with a potential range of 0--18.[17](#jcsm12048-bib-0017){ref-type="ref"}

Construct validity measures (cross‐sectional and longitudinal) {#jcsm12048-sec-0010}
--------------------------------------------------------------

Instrumental Activity of Daily Living (IADL) difficulty in AAH covered eight items (preparing meals, shopping for groceries, managing money, making phone calls, doing light housework, doing heavy housework, getting to places outside walking distance, and managing medications) from the Second Longitudinal Study on Aging[18](#jcsm12048-bib-0018){ref-type="ref"} and Lawton and Brody[19](#jcsm12048-bib-0019){ref-type="ref"} and was scored as the number of tasks for which the respondent reported difficulty performing or unable to perform it without help. IADL difficulty in BLSA included seven of the eight AAH items except getting to places outside walking distance and was scored as the number of tasks for which the respondent reported difficulty performing or unable to perform without help.

Hospitalization was based on respondent reports of one or more overnight hospitalizations in the year prior to Wave 4 (2004) and Wave 10 (2010) in AAH and of one or more overnight hospitalizations in the year prior to each respondent\'s NHANES interview (1999--2002).

For gait speed in AAH, a 3 m or 4 m course in participants\' homes was used, with participants instructed to walk at their usual pace, as if walking to the store. The average walking speed (m/s) for two trials was used to create a dichotomous variable for gait speed average of \<0.8 vs. ≥0.8 m/s. A walk course was set up in the testing centre to measure time to complete a 20 ft walk (seconds) in NHANES.

The short physical performance battery (SPPB) measure of lower body performance is based on three component tasks: standing balance, repeated chairs stands, and usual walking speed.[20](#jcsm12048-bib-0020){ref-type="ref"} Each component task was scored as 0--4 (0 = *worst* to 4 = *best*), and a composite score was computed as the sum of scores on component tasks as 0--12 (0 = *worst* to 12 = *best*). Complete details on the composite SPPB score in AAH are provided by Miller and colleagues.[21](#jcsm12048-bib-0021){ref-type="ref"}

Chair stands in AAH were measured as the time (maximum of 60 s) it took participants to complete five rises and returns when instructed to complete the task as fast as possible.

Grip strength testing in AAH was performed in the self‐reported stronger hand using either a Jamar (Preston Corp, Jackson, MI) or a baseline (Fabrication Enterprises, Inc., Irvington, NY) isometric dynamometer (pre‐testing showed equivalent results using either instrument) and defined as the average (kg) of three maximal trials. Grip strength testing in BLSA was done for both hands and scored as the average (kg) of three trials for each hand separately.

Knee extensor strength testing in NHANES was done using a Kin Com MP dynamometer (Chattanooga Group, Inc., Chattanooga, TN). Peak torque (Newton/metres) of the quadriceps was measured at 60°/s.

Frailty in AAH was measured using the FRAIL scale.[11](#jcsm12048-bib-0011){ref-type="ref"} FRAIL includes five components: fatigue, resistance, ambulation, illness, and loss of weight. FRAIL scores range from 0 to 5 (i.e. 1 point for each component; 0 = *best* to 5 = *worst*).

Vital status up to 6 years later in AAH was determined by proxy report as part of the annual AAH follow‐up interview plus tracing via local databases (e.g. obituaries). Results were coded 1 for decedents and 0 for survivors. Vital status up to 9.75 years later in BLSA was coded 1 for decedents and 0 for survivors.

Statistics {#jcsm12048-sec-0011}
----------

Data were analysed using IBM SPSS Statistics, version 21 (Somers, NY). Descriptive statistics are reported as means ± standard deviations, median and interquartile range, or percentages. *T*‐test for continuous variables and chi‐square for categorical variables were used to compare socio‐demographic characteristics of study groups. Internal consistency reliability was evaluated using Cronbach\'s alpha. Principal components analysis was performed to investigate the homogeneity of SARC‐F items. SARC‐F associations with muscle mass, SPSM, and frailty were examined using Spearman\'s rho correlation. Analysis of covariance (continuous outcomes) and logistic regression (dichotomous outcomes) were used to compare participants with SARC‐F scores ≥ 4 vs. \< 4 in cross‐sectional outcomes. Linear regression (continuous outcomes) and logistic regression (dichotomous outcomes) were used to examine the association of SARC‐F score ≥ 4 vs. \< 4 for longitudinal outcomes and for SARC‐F items with cross‐sectional and longitudinal outcomes. Means ± standard deviations are reported for analyses of covariance, adjusted odds ratios (ORs) and 95% confidence intervals (CIs) are reported for logistic regression analyses, and unstandardized (B) regression coefficients and standard errors are reported for linear regression analyses. Cross‐sectional analyses were adjusted for age and gender, and longitudinal analyses were adjusted for age, gender, and baseline values of all validating variables except mortality.

Results {#jcsm12048-sec-0012}
=======

SARC‐F total scores (0--10) median (interquartile range) were 0 (0--2) in AAH, 0 (0 and 1) in BLSA, and 0 (0--2) in NHANES. There were 18.4% (157/853) AAH, 6.3% (66/1053) BLSA, and 15.4% (505/3288) NHANES participants with a SARC‐F score ≥ 4 (SARC‐F positive). The characteristics of the SARC‐F positive and SARC‐F negative groups are shown in *Table* [1](#jcsm12048-tbl-0001){ref-type="table-wrap"} and demonstrated the expected findings (e.g. lower household income in the SARC‐F positive group). The five‐item SARC‐F alphas were 0.81 (AAH), 0.78 (BLSA), and 0.76 (NHANES). The principal components SARC‐F analyses yielded a single factor that accounted for 57.2% (AAH), 56.7% (BLSA), and 53.5% (NHANES) of variance. SARC‐F item loadings (AAH, BLSA, and NHANES) were as follows: strength (0.81, 0.80, 0.76), assistance walking (0.81, 0.84, 0.76), rise from a chair (0.80, 0.76, 0.80), climb stairs (0.81, 0.88, 0.80), and falls (0.50, 0.39, 0.49). SARC‐F in the AAH cohort correlated with Tanita lean mass per cent (*r* = −0.20; *P* = 0.001), Tanita lean mass total (lbs; *r* = −0.07, *P* = 0.046), and the SPSM (*r* = −0.34; *P* \< 0.001).

###### 

Demographic characteristics among participants with high (≥4) vs. low (\<4) SARC‐F scores

  -------------------------------------------------- ------------------- ----------------- ----------------------------------------------------
                                                     SARC‐F scores ≥ 4                     
  African American Health                            Yes (*n* = 157)     No (*n* = 696)    *P*‐value[\*](#jcsm12048-note-0002){ref-type="fn"}
  Age (mean ± SD)                                    59.95 ± 4.5         59.00 ± 4.3       0.013
  Women (%)                                          71.3                60.6              0.012
  Years of education (mean ± SD)                     11.57 ± 2.8         12.69 ± 2.9       \<0.001
  Annual household income below 25 K (%)             77.1                44.1              \<0.001
  City area (%)                                      55.4                42.7              0.004
  Self‐rated health: fair or poor (%)                81.5                26.3              \<0.001
                                                     SARC‐F scores ≥ 4                     
  Baltimore Longitudinal Study of Aging              Yes (*n* = 66)      No (*n* = 987)    *P*‐value[\*](#jcsm12048-note-0002){ref-type="fn"}
  Age (mean ± SD)                                    72.74 ± 8.7         85.35 ± 9.2       \<0.001
  Women (%)                                          60.6                46.6              0.019
  Race (%)                                                                                 0.019
  White                                              89.4                74.4              
  Black or African American                          10.6                21.0              
  Other race                                         0                   4.6               
  Years of education (mean ± SD)                     15.33 ± 3.0         16.81 ± 2.7       \<0.001
  Annual household income below 25 K (%)             16.7                4.9               0.011
  Self‐rated health: fair or poor (%)                38.6                4.2               \<0.001
                                                     SARC‐F scores ≥ 4                     
  National Health and Nutrition Examination Survey   Yes (*n* = 505)     No (*n* = 2783)   *P*‐value[\*](#jcsm12048-note-0002){ref-type="fn"}
  Age (mean ± SD)                                    75.76 ± 8.2         71.30 ± 7.8       \<0.001
  Women (%)                                          66.5                49.1              \<0.001
  Race (%)                                                                                 0.711
  Mexican American                                   18.4                19.9              
  Other Hispanic                                     4.8                 3.9               
  Non‐Hispanic White                                 57.0                58.2              
  Non‐Hispanic Black                                 17.4                16.0              
  Other race                                         2.4                 2.1               
  Education (%)                                                                            \<0.001
  Less than high school                              55.2                40.8              
  High school/GED                                    20.2                24.1              
  More than high school                              24.6                35.1              
  Annual household income below 20 K (%)             54.5                33.1              \<0.001
  -------------------------------------------------- ------------------- ----------------- ----------------------------------------------------

GED, general educational development; SD, standard deviation.

*T*‐test for continuous variables and chi‐square for categorical variables.

Cross‐sectional results {#jcsm12048-sec-0013}
-----------------------

Health outcomes (disability, physical performance, strength, and utilization) for those with SARC‐F ≥ 4 vs. \< 4 in the AAH, BLSA, and NHANES cohorts are shown in *Table* [2](#jcsm12048-tbl-0002){ref-type="table-wrap"}. AAH participants with SARC‐F scores ≥ 4 had more IADL deficits than those with SARC‐F scores of 3 or less, slower chair stands times, lower grip strength, and lower SPPB scores (*P~s~* ≤ 0.001). SARC‐F scores ≥ 4 in AAH also were associated with a higher likelihood of being hospitalized overnight in the past year and having a gait speed of \<0.8 m/s (*P~s~* ≤ 0.001). The correlation between total SARC‐F scores (0--10) and FRAIL scale scores (0--5) was 0.70 (*P* \< 0.001) in AAH. SARC‐F scores ≥ 4 in BLSA were associated with higher IADL difficulties and worse grip strength in both the right and left hands (*P~s~* ≤ 0.001). NHANES participants with SARC‐F scores ≥ 4 exhibited slower times to walk 20 ft, lower strength (knee extension), and increased likelihood of being hospitalized overnight in the past year (*P~s~* ≤ 0.001). Similar associations were seen in cross‐sectional comparisons for SARC‐F items and outcomes in AAH, BLSA, and NHANES (*Table* [3](#jcsm12048-tbl-0003){ref-type="table-wrap"}).

###### 

Construct validity: cross‐sectional comparisons for health outcomes among participants with high (≥4) vs. low (\<4) SARC‐F scores

  -------------------------------------------------- --------------------- ---------------------------------------------------- ----------------------------------------------------
                                                     SARC‐F scores ≥ 4                                                          
  African American Health                            Yes                   No                                                   *P*‐value[\*](#jcsm12048-note-0004){ref-type="fn"}
  IADLs (0--8)                                       3.67 ± 2.0            0.42 ± 0.9                                           \<0.001
  Chair stands (s)                                   15.25 ± 5.2           11.30 ± 3.5                                          \<0.001
  Grip strength (kg)                                 26.23 ± 11.1          32.52 ± 11.6                                         \<0.001
  Short physical performance battery (0--12)         4.78 ± 3.1            8.90 ± 2.3                                           \<0.001
                                                     Odds ratio (95% CI)   *P*‐value[\*](#jcsm12048-note-0004){ref-type="fn"}   
  Hospitalized overnight in the past year            3.94 (2.66--5.83)     \<0.001                                              
  Gait speed \< 0.8 m/s                              5.73 (3.28--10.00)    \<0.001                                              
                                                     SARC‐F scores ≥ 4                                                          
  Baltimore Longitudinal Study of Aging              Yes                   No                                                   *P*‐value[\*](#jcsm12048-note-0004){ref-type="fn"}
  IADLs (0--7)                                       3.74 ± 2.4            0.23 ± 0.7                                           \<0.001
  Grip strength, right hand (kg)                     17.92 ± 8.4           29.62 ± 10.2                                         0.004
  Grip strength, left hand (kg)                      16.80 ± 8.1           28.25 ± 10.1                                         0.012
                                                     SARC‐F scores ≥ 4                                                          
  National Health and Nutrition Examination Survey   Yes                   No                                                   *P*‐value[\*](#jcsm12048-note-0004){ref-type="fn"}
  20 ft walk (s)                                     10.18 ± 4.9           6.86 ± 2.58                                          \<0.001
  Peak force, knee extensor strength                 198.21 ± 69.4         258.15 ± 88.77                                       \<0.001
                                                     Odds ratio (95% CI)   *P*‐value[\*](#jcsm12048-note-0004){ref-type="fn"}   
  Hospitalized overnight in the past year            2.53 (2.01--3.19)     \<0.001                                              
  -------------------------------------------------- --------------------- ---------------------------------------------------- ----------------------------------------------------

CI, confidence interval; IADLs, Instrumental Activities of Daily Living.

Analysis of covariance for continuous outcomes and logistic regression for dichotomous outcomes. Analyses adjusted for age and gender.

###### 

Construct validity: cross‐sectional comparisons for health outcomes with SARC‐F items[\*](#jcsm12048-note-0002){ref-type="fn"}

  ----------------------------------------- --------------------------------------- ----------- -------------------------------------------------- ----------------------------- -----------
  African American Health                   Baltimore Longitudinal Study of Aging                                                                                                
                                            Unstandardized coefficients                                                                            Unstandardized coefficients   
                                            B (SE)                                  *P*‐value                                                      B (SE)                        *P*‐value
  IADLs (0--8)                                                                                                     IADLs (0--7)                                                  
  Strength                                  1.55 (0.06)                             \<0.001                          Strength                      1.68 (0.07)                   \<0.001
  Assistance walking                        1.97 (0.07)                             \<0.001                     Assistance walking                 1.76 (0.07)                   \<0.001
  Rise from a chair                         1.88 (0.08)                             \<0.001                     Rise from a chair                  1.39 (0.07)                   \<0.001
  Climb stairs                              1.65 (0.06)                             \<0.001                        Climb stairs                    1.48 (0.06)                   \<0.001
  Falls                                     0.92 (0.10)                             \<0.001                           Falls                        0.52 (0.07)                   \<0.001
  Chair stands (s)                                                                                        Grip strength, right hand (kg)                                         
  Strength                                  1.89 (0.26)                             \<0.001                                                                                      
  Assistance walking                        2.76 (0.37)                             \<0.001                          Strength                      −2.77 (0.63)                  \<0.001
  Assistance walking                        −2.17 (0.62)                            \<0.001                                                                                      
  Rise from a chair                         2.98 (0.39)                             \<.001                                                                                       
  Climb stairs                              2.35 (0.27)                             \<0.001                     Rise from a chair                  −1.95 (0.60)                  0.001
  Falls                                     1.21 (0.29)                             \<0.001                        Climb stairs                    −1.81 (0.59)                  0.002
                                                                                                                      Falls                        −0.69 (0.46)                  0.131
  Grip strength (kg)                                                                                      Grip strength, left hand (kg)                                          
  Strength                                  −2.70 (0.46)                            \<0.001                                                                                      
  Assistance walking                        −1.53 (0.57)                            0.007                            Strength                      −2.60 (0.62)                  \<0.001
  Assistance walking                        −1.71 (0.63)                            0.007                                                                                        
  Rise from a chair                         −1.77 (0.58)                            0.002                                                                                        
  Climb stairs                              −2.53 (0.48)                            \<0.001                     Rise from a chair                  −1.83 (0.58)                  0.002
  Falls                                     −1.12 (0.57)                            0.051                          Climb stairs                    −1.65 (0.57)                  0.004
                                                                                                                      Falls                        −0.10 (0.44)                  0.815
  SPPB (0--12)                                                                                                                                                                   
  Strength                                  −2.03 (0.13)                            \<0.001                                                                                      
  Assistance walking                        −2.73 (0.17)                            \<0.001                                                                                      
  Rise from a chair                         −2.37 (0.18)                            \<0.001                                                                                      
  Climb stairs                              −2.33 (0.13)                            \<0.001                                                                                      
  Falls                                     −1.35 (0.18)                            \<0.001                                                                                      
                                                                                                 National Health and Nutrition Examination Survey                                
                                                                                                                                                   Unstandardized coefficients   
                                            Odds ratio (95% CI)                     *P*‐value                                                      B (SE)                        *P*‐value
  Hospitalized overnight in the past year                                                                         20 ft walk (s)                                                 
  Strength                                  2.14 (1.73--2.65)                       \<0.001                          Strength                      1.38 (0.09)                   \<0.001
  Assistance walking                        2.36 (1.85--3.02)                       \<0.001                     Assistance walking                 3.21 (0.22)                   \<0.001
  Rise from a chair                         1.98 (1.54--2.56)                       \<0.001                     Rise from a chair                  1.55 (0.11)                   \<0.001
  Climb stairs                              2.09 (1.67--2.62)                       \<0.001                        Climb stairs                    1.44 (0.09)                   \<0.001
  Falls                                     1.97 (1.49--2.59)                       \<0.001                           Falls                        0.93 (0.10)                   \<0.001
  Gait speed \< 0.8 m/s                                                                                          Peak force, knee                                                
  Strength                                  2.65 (1.96--3.59)                       \<0.001                          Strength                      −16.43 (3.07)                 \<0.001
  Assistance walking                        5.02 (2.75--9.15)                       \<0.001                     Assistance walking                 −32.87 (8.42)                 \<0.001
  Rise from a chair                         2.92 (1.96--4.36)                       \<0.001                     Rise from a chair                  −24.22 (3.72)                 \<0.001
  Climb stairs                              3.07 (2.21--4.24)                       \<0.001                        Climb stairs                    −21.89 (3.16)                 \<0.001
  Falls                                     1.49 (1.11--1.99)                       0.008                             Falls                        −14.12 (3.28)                 \<0.001
                                            Odds ratio (95% CI)                     *P*‐value                                                                                    
  Hospitalized overnight in the past year                                                                                                                                        
  Strength                                  1.75 (1.54--1.99)                       \<0.001                                                                                      
  Assistance walking                        1.77 (1.44--2.17)                       \<0.001                                                                                      
  Rise from a chair                         1.68 (1.45--1.94)                       \<0.001                                                                                      
  Climb stairs                              1.73 (1.52--1.97)                       \<0.001                                                                                      
  Falls                                     1.62 (1.41--1.86)                       \<0.001                                                                                      
  ----------------------------------------- --------------------------------------- ----------- -------------------------------------------------- ----------------------------- -----------

CI, confidence interval; IADLs, Instrumental Activities of Daily Living; SE, standard error; SPPB, short physical performance battery.

Linear regression for continuous outcomes and logistic regression for dichotomous outcomes. Analyses adjusted for age and gender.

Longitudinal results {#jcsm12048-sec-0014}
--------------------

SARC‐F scores ≥ 4 predicted hospitalization and gait speed of \<0.8 m/s at 6 year follow‐up in the AAH (*P~s~* ≤ 0.05; *Table* [4](#jcsm12048-tbl-0004){ref-type="table-wrap"}). SARC‐F scores ≥ 4 were also associated with more IADL deficits, slower chair stands times, and lower SPPB scores (*P~s~* ≤ 0.01) at 6 year follow‐up in AAH. Grip strength was lower for those with SARC‐F scores ≥ 4 (27 ± 12) vs. \< 4 (32 ± 11) at 6 year follow‐up in AAH, but this difference was not statistically significant (*P* = 0.288). AAH SARC‐F scores ≥ 4 predicted 6 year mortality (OR = 1.87, 95% CI 1.17--2.98; *P* = 0.009) and included 19.7% of persons who died compared with 11.9% of non‐SARC‐F positive persons who died. SARC‐F scores ≥ 4 were associated with more IADL deficits, lower grip strength right hand, and lower grip strength left hand (*P~s~* ≤ 0.05) at follow‐up in BLSA. SARC‐F scores ≥ 4 vs. \< 4 also predicted mortality (OR = 3.0, 95% CI 1.57--5.73; *P* \< 0.001) in BLSA. Mortality for BLSA participants was 39.4% for SARC‐F ≥ 4 vs. 8.0% for SARC‐F \< 4. A mortality analysis including only BLSA participants with at least 2 years of follow‐up yielded similar results for SARC‐F scores ≥ 4 vs. \< 4 (OR = 2.69, 95% CI 1.39--5.21; *P* \< 0.001). Similar associations were seen in longitudinal comparisons for SARC‐F items and outcomes in AAH and BLSA (*Table* [5](#jcsm12048-tbl-0005){ref-type="table-wrap"}).

###### 

Construct validity: longitudinal comparisons for health outcomes among participants with high (≥4) vs. low (\<4) SARC‐F scores[\*](#jcsm12048-note-0008){ref-type="fn"}

  ------------------------------------------------------- ----------------------------- ----------------------------------------------------
  African American Health                                 SARC‐F scores ≥ 4             
                                                          Odds ratio (95% CI)           *P*‐value[\*](#jcsm12048-note-0008){ref-type="fn"}
  Hospitalized overnight in the past year                 2.43 (1.46--4.05)             \<0.001
  Gait speed \< 0.8 m/s                                   2.46 (1.13--5.34)             0.023
  Mortality                                               1.87 (1.17--2.98)             0.009
                                                          Unstandardized coefficients   *P*‐value[\*](#jcsm12048-note-0008){ref-type="fn"}
  B (SE)                                                                                
  Instrumental Activities of Daily Living (IADLs; 0--8)   0.78 (0.27)                   0.004
  Chair stands (s)                                        3.14 (1.1)                    0.004
  Grip strength (kg)                                      −1.07 (1.0)                   0.288
  Short physical performance battery (0--12)              −0.29 (0.08)                  \<0.001
  Baltimore Longitudinal Study of Aging                   SARC‐F scores ≥ 4             
                                                          Unstandardized coefficients   *P*‐value[\*](#jcsm12048-note-0008){ref-type="fn"}
  B (SE)                                                                                
  IADLs (0--7)                                            1.24 (0.22)                   \<0.001
  Grip strength, right hand (kg)                          −2.44 (1.19)                  0.041
  Grip strength, left hand (kg)                           −2.96 (1.26)                  0.019
                                                          Odds ratio (95% CI)           *P*‐value[\*](#jcsm12048-note-0008){ref-type="fn"}
  Mortality                                               3.00 (1.57--5.73)             \<0.001
  ------------------------------------------------------- ----------------------------- ----------------------------------------------------

CI, confidence interval; SE, standard error.

Linear regression for continuous outcomes and logistic regression for dichotomous outcomes. Mortality analyses adjusted for age and gender. All other analyses adjusted for age, gender, and baseline value of the outcome variable being examined.

###### 

Construct validity: longitudinal comparisons for health outcomes with SARC‐F items[\*](#jcsm12048-note-0008){ref-type="fn"}

  -------------------------------------------- ------------------------------------ -----------
  African American Health                      Unstandardized coefficients B (SE)   *P*‐value
  IADLs                                                                             
  Strength                                     0.53 (0.13)                          \<0.001
  Assistance walking                           −0.04 (0.17)                         0.820
  Rise from a chair                            0.44 (0.16)                          0.005
  Climb stairs                                 0.78 (0.15)                          \<0.001
  Falls                                        0.15 (0.13)                          0.246
  Chair stands (s)                                                                  
  Strength                                     1.10 (0.60)                          0.070
  Assistance walking                           2.46 (0.90)                          0.007
  Rise from a chair                            1.78 (0.86)                          0.039
  Climb stairs                                 1.06 (0.65)                          0.107
  Falls                                        0.08 (0.58)                          0.898
  Grip strength (kg) Mortality                                                      
  Strength                                     −0.40 (0.55)                         0.473
  Assistance walking                           −0.39 (0.68)                         0.561
  Rise from a chair                            −0.91 (0.64)                         0.161
  Climb stairs                                 −0.22 (0.57)                         0.703
  Falls                                        −0.37 (0.63)                         0.559
  Short physical performance battery (0--12)                                        
  Strength                                     −0.68 (0.22)                         0.002
  Assistance walking                           −0.45 (0.30)                         0.131
  Rise from a chair                            −1.06 (0.25)                         \<0.001
  Climb stairs                                 −1.05 (0.23)                         \<0.001
  Falls                                        0.11 (0.24)                          0.649
                                               Odds ratio (95% CI)                  *P*‐value
  Hospitalized overnight in the past year                                           
  Strength                                     1.67 (1.27--2.21)                    \<0.001
  Assistance walking                           1.55 (1.11--2.17)                    0.010
  Rise from a chair                            2.06 (1.51--2.83)                    \<0.001
  Climb stairs                                 1.52 (1.13--2.05)                    0.006
  Falls                                        1.83 (1.29--2.59)                    \<0.001
  Gait speed \< 0.8 m/s                                                             
  Strength                                     1.33 (0.87--2.02)                    0.182
  Assistance walking                           1.43 (0.78--2.62)                    0.254
  Rise from a chair                            1.71 (1.00--2.92)                    0.050
  Climb stairs                                 1.50 (0.96--2.35)                    0.077
  Falls                                        0.79 (0.52--1.21)                    0.278
  Mortality                                                                         
  Strength                                     1.43 (1.11--1.85)                    0.005
  Assistance walking                           1.43 (1.07--1.90)                    0.015
  Rise from a chair                            1.26 (0.92--1.75)                    0.147
  Climb stairs                                 1.59 (1.21--2.02)                    \<0.001
  Falls                                        1.04 (0.74--1.49)                    0.807
  Baltimore Longitudinal Study of Aging        Unstandardized coefficients B (SE)   *P*‐value
  IADLs (0--7)                                                                      
  Strength                                     0.30 (0.11)                          0.007
  Assistance walking                           0.74 (0.11)                          \<0.001
  vRise from a chair                           0.44 (0.10)                          \<0.001
  Climb stairs                                 0.29 (0.11)                          0.007
  Falls                                        0.10 (0.07)                          0.151
  Grip strength, right hand (kg)                                                    
  Strength                                     −1.32 (0.62)                         0.035
  Assistance walking                           −0.94 (0.62)                         0.129
  Rise from a chair                            −1.56 (0.56)                         0.006
  Climb stairs                                 −1.18 (0.59)                         0.045
  Falls                                        −0.15 (0.37)                         0.695
  Grip strength, left hand (kg)                                                     
  Strength                                     −0.18 (0.69)                         0.800
  Assistance walking                           −1.17 (0.70)                         0.097
  Rise from a chair                            −1.99 (0.59)                         \<0.001
  Climb stairs                                 −0.78 (0.65)                         0.229
  Falls                                        −0.49 (0.39)                         0.215
                                               Odds ratio (95% CI)                  *P*‐value
  Mortality                                                                         
  Strength                                     1.89 (1.30--2.74)                    \<0.001
  Assistance walking                           1.30 (0.91--1.84)                    0.145
  Rise from a chair                            1.64 (1.12--2.39)                    0.011
  Climb stairs                                 1.45 (1.03--2.04)                    0.035
  Falls                                        1.26 (0.86--1.84)                    0.244
  -------------------------------------------- ------------------------------------ -----------

CI, confidence interval; IADLs, Instrumental Activities of Daily Living; SE, standard error.

Linear regression for continuous outcomes and logistic regression for dichotomous outcomes. Mortality analyses adjusted for age and gender. All other analyses adjusted for age, gender, and baseline value of the outcome variable being examined.

Discussion {#jcsm12048-sec-0015}
==========

This study demonstrated that a simple clinical score, SARC‐F, predicts clinically significant outcomes over the subsequent 6 years in AAH and BLSA. The components of SARC‐F are those that would be expected to be associated with poor muscle function. Thus, it is not surprising that cross‐sectional SARC‐F correlates with knee strength (NHANES) and grip strength (AAH and BLSA). SARC‐F also correlates and with frailty on the self‐reported FRAIL scale (AAH). The objective of case finding is to identify persons at high risk for adverse outcomes. Based on these findings, SARC‐F would be an adequate tool to identify persons with muscle weakness that may be amenable to treatment. At present, the major treatment would be resistance exercise and possibly other forms of exercise coupled with increased protein intake.[22](#jcsm12048-bib-0022){ref-type="ref"}, [23](#jcsm12048-bib-0023){ref-type="ref"}, [24](#jcsm12048-bib-0024){ref-type="ref"}, [25](#jcsm12048-bib-0025){ref-type="ref"} This study suggests that SARC‐F is a rapid, question‐based clinical tool that may be a useful sarcopenia screen for primary care physicians. This would then allow referral of persons with positive SARC‐F scores for further evaluation and to involve them in resistance exercise programmes.[26](#jcsm12048-bib-0026){ref-type="ref"}, [27](#jcsm12048-bib-0027){ref-type="ref"} Testosterone may be useful, but its safety has been questioned.[28](#jcsm12048-bib-0028){ref-type="ref"} A number of drugs such as selective androgen receptor molecules, myostatin inhibitors, and ghrelin agonists are being developed to treat sarcopenia[29](#jcsm12048-bib-0029){ref-type="ref"}; if and when proven effective, they may benefit SARC‐F positive patients.

This approach is similar to the one emerging for fracture risk. Two studies have shown that using the questions included in the FRAX risk assessment tool ([www.shef.ac.uk/FRAX](http://www.shef.ac.uk/FRAX)), the population can be divided into low risk, intermediate risk, and high risk.[30](#jcsm12048-bib-0030){ref-type="ref"} If BMD is only measured in those at intermediate risk, the need to measure BMD is avoided in 70% of the population. Selective use of BMD testing had a sensitivity of 87% for identifying fragility fractures. As commonly used definitions of sarcopenia require low gait speed and an appendicular muscle mass corrected for height squared, it would seem that those who are SARC‐F positive might need to undergo this more extensive testing.

This study has limitations. There were some differences in the items used to construct the SARC‐F in AAH and BLSA vs. NHANES. In particular, the SARC‐F falls item computed using the NHANES cohort data did not include the number of falls in the past year but rather whether respondents had balance problems or falling problems in the past year. NHANES respondents with falling problems may have had fewer than four falls in the past year, and those who report balance problems but not falling problems may not have had any falls in the past year. Thus, we were not able to determine the number of falls for NHANES respondents, so we were only able to approximate the SARC‐F falls item and scoring in NHANES via self‐reported balance or falling problems. Some outcomes were not available in all cohorts, or the valid sample size was too small for some outcomes to be included in this study. Another limitation is that the AAH cohort included late middle‐aged adults at baseline, so the prevalence of sarcopenia among African Americans likely would be higher in an older cohort. On the other hand, late middle age is probably a good time to identify sarcopenia so that it can be stabilized or reversed in time to prevent adverse outcomes, and African Americans are more likely to have frailty.[31](#jcsm12048-bib-0031){ref-type="ref"} The BLSA cohort does include older adults, but this group is high functioning when enrolled in the study. SARC‐F correlations with the performance‐based SPSM (AAH) and with muscle mass by bioelectrical impedance (AAH) were modest overall. Thus, additional studies are needed to examine SARC‐F\'s validity in other populations and against standard definitions of sarcopenia (e.g. European Working Group on Sarcopenia in Older People) in prospective studies and to investigate the ability of treatment programs to lower SARC‐F scores or prevent adverse outcomes in patients with SARC‐F positive. There are currently no data available on the optimal interval or age to screen for sarcopenia. Empirical evidence is also needed to demonstrate that sarcopenia interventions have efficacy for clinical outcomes prior to screening for this syndrome in primary care.

In summary, we developed a simple self‐report questionnaire (SARC‐F) to screen for persons with sarcopenia. The SARC‐F includes five items based on cardinal features or consequences of sarcopenia. This study provides evidence that the SARC‐F scale in AAH, BLSA, and NHANES cohorts is internally consistent and valid for detecting persons at risk for adverse outcomes from sarcopenia.

Conflict of interest {#jcsm12048-sec-0017}
====================

None declared.

This research was supported in part by a grant from the National Institute on Aging to Dr D. K. Miller (R01 AG010436) and in part by the Intramural Research Program of the National Institute on Aging. The authors of this manuscript certify that they comply with the guidelines of ethical authorship and publishing as stated in the Journal of Cachexia, Sarcopenia, and Muscle 2010; 1:7--8 (von Haehling S, Morley JE, Coats AJ, and Anker SD).
